LeMaitre Vascular, Inc. (LMAT)

NASDAQ: LMAT · IEX Real-Time Price · USD
47.48
+1.40 (3.04%)
Jul 7, 2022 1:25 PM EDT - Market open
3.04%
Market Cap 1.05B
Revenue (ttm) 158.10M
Net Income (ttm) 27.02M
Shares Out 22.19M
EPS (ttm) 1.24
PE Ratio 38.29
Forward PE 37.17
Dividend $0.47 (0.99%)
Ex-Dividend Date May 16, 2022
Volume 25,074
Open 46.38
Previous Close 46.08
Day's Range 45.86 - 47.49
52-Week Range 38.32 - 61.02
Beta 1.28
Analysts Buy
Price Target 61.05 (+28.6%)
Earnings Date Aug 4, 2022

About LMAT

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the ... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Oct 19, 2006
CEO George LeMaitre
Employees 450
Stock Exchange NASDAQ
Ticker Symbol LMAT
Full Company Profile

Financial Performance

In 2021, LMAT's revenue was $154.42 million, an increase of 19.37% compared to the previous year's $129.37 million. Earnings were $26.91 million, an increase of 26.80%.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is 61.05, which is an increase of 28.58% from the latest price.

Price Target
$61.05
(28.58% upside)
Analyst Consensus: Buy
Stock Forecasts

News

LeMaitre to Present at the Sidoti Summer Small Cap Virtual Conference

BURLINGTON, Mass., June 03, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Sidoti Summer Small Cap Virtual Conference o...

LeMaitre to Present at Upcoming Investor Conferences

BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.

LeMaitre Vascular (LMAT) Q1 Earnings Miss Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of -3.57% and 1.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

LeMaitre Q1 2022 Financial Results

BURLINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2022 results, announced a $0.125/share quarterly di...

LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022

BURLINGTON, Mass., April 15, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2022 financial results on Thursday, April 28, 2022, aft...

Is This Overlooked Stock a Buy After Its Dividend Hike?

LeMaitre Vascular could be a hidden gem for dividend growth investors.

LeMaitre to Present at the Needham Virtual Healthcare Conference

BURLINGTON, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 21st Annual Needham Virtual H...

LeMaitre Joins NASDAQ Dividend Achievers Index – 10 Years of Dividend Increases

BURLINGTON, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it has joined the NASDAQ US Broad Dividend Achie...

LeMaitre to Participate at Upcoming Investor Conferences in March

BURLINGTON, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.

LeMaitre Vascular (LMAT) Misses Q4 Earnings and Revenue Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of -9.68% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

LeMaitre Q4 2021 Financial Results

BURLINGTON, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2021 results, announced a $0.125/share quarterly div...

Analysts Estimate LeMaitre Vascular (LMAT) to Report a Decline in Earnings: What to Look Out for

LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022

BURLINGTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2021 financial results on Thursday, February 24, 2022, ...

LeMaitre to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

BURLINGTON, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the BTIG MedTech, Digital Health, ...

AHCO vs. LMAT: Which Stock Should Value Investors Buy Now?

AHCO vs. LMAT: Which Stock Is the Better Value Option?

Other symbols: AHCO

LeMaitre to Present at the Needham Virtual Growth Conference

BURLINGTON, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 24th Annual Needham Virtual Gr...

Why You Should Consider Buying This Little-Known Medical Devices Stock

LeMaitre Vascular is a small-cap medical devices maker with the potential to continue growing rapidly in the years ahead.

LeMaitre to Participate at Upcoming Investor Conferences

BURLINGTON, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming virtual investor conferences.

LeMaitre Vascular (LMAT) Lags Q3 Earnings and Revenue Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of -9.09% and -2.58%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Recap: LeMaitre Vascular Q3 Earnings

LeMaitre Vascular (NASDAQ:LMAT) reported its Q3 earnings results on Thursday, October 28, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

LeMaitre Q3 2021 Financial Results

BURLINGTON, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2021 results, announced an $0.11/share quarterly div...

LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021

BURLINGTON, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2021 financial results on Thursday, October 28, 2021, af...

5 High-Quality Stocks Outperforming the S&P 500

In light of increasing market volatility, five stocks with high business quality and have outperformed the Standard & Poor's 500 index in the year to date are Alphabet Inc. ( GOOGL , Financial)( GOOG , ...

Other symbols: DSGXGOOGGOOGLODFLWST

LeMaitre Vascular to Participate at Upcoming Investor Conferences in September

BURLINGTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four virtual investor conferences in September.

Is This Under-the-Radar Medical Device Company a Post-Earnings Buy?

LeMaitre Vascular's operating fundamentals and balance sheet suggest it's a buy, depending on your objectives.